Related Experiment Videos

Insulin-degrading activity and insulinase-inhibiting activity in acute leukemia

L Rageliene1, V Urbanavicius, V Matulevicius

  • 1Vilnius Republic Children's Hospital, Vilnius.

Padiatrie Und Grenzgebiete
|January 1, 1990
PubMed

Insights

Insulin-degrading activity remained unchanged in children with acute leukemia. However, insulinase-inhibiting activity in blood and erythrocytes increased during the active disease stage in pediatric leukemia patients.

Area of Science:

  • Biochemistry
  • Pediatric Oncology
  • Hematology

Background:

  • Acute leukemia is a significant pediatric cancer.
  • Insulin metabolism plays a role in various physiological and pathological processes.
  • Understanding metabolic alterations in pediatric leukemia is crucial for treatment.

Purpose of the Study:

  • To investigate insulin-degrading and insulinase-inhibiting activity in children with acute leukemia.
  • To compare these activities between patients and healthy children.
  • To assess the impact of disease stage on these enzymatic activities.

Main Methods:

  • Analysis of whole blood and erythrocyte samples from 146 children with acute leukemia.
  • Measurement of insulin-degrading enzyme activity.
  • Assessment of insulinase-inhibiting activity in blood hemolysate and erythrocytes.

Main Results:

  • No significant difference in insulin-degrading activity was observed between children with acute leukemia and healthy controls.
  • Insulinase-inhibiting activity was found to be elevated in the hemolysate of blood and erythrocytes of children in the active stage of acute leukemia.

Conclusions:

  • Insulin degradation is not significantly altered in pediatric acute leukemia.
  • Elevated insulinase-inhibiting activity in active-stage acute leukemia suggests a potential role in disease pathophysiology.
  • Further research is warranted to explore the clinical implications of altered insulinase inhibition in pediatric leukemia.

Related Concept Videos